Home
Esportazione
Statistica
Opzioni
Visualizza tutti i metadati (visione tecnica)
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.
Bonifacio, M
•
Binotto, G
•
Maino, E
altro
TIRIBELLI, Mario
2015
journal article
Periodico
HAEMATOLOGICA
WOS
WOS:000365045100003
Archivio
http://hdl.handle.net/11390/1071149
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84938586091
Diritti
open access
Visualizzazioni
3
Data di acquisizione
Apr 19, 2024
Vedi dettagli
google-scholar
Vedi dettagli